354 related articles for article (PubMed ID: 38255995)
1. The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy.
Carrera-Aguado I; Marcos-Zazo L; Carrancio-Salán P; Guerra-Paes E; Sánchez-Juanes F; Muñoz-Félix JM
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255995
[TBL] [Abstract][Full Text] [Related]
2. Tumor vessel co-option: The past & the future.
Cuypers A; Truong AK; Becker LM; Saavedra-García P; Carmeliet P
Front Oncol; 2022; 12():965277. PubMed ID: 36119528
[TBL] [Abstract][Full Text] [Related]
3. Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases.
Haas G; Fan S; Ghadimi M; De Oliveira T; Conradi LC
Front Cell Dev Biol; 2021; 9():612774. PubMed ID: 33912554
[TBL] [Abstract][Full Text] [Related]
4. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
[TBL] [Abstract][Full Text] [Related]
5. Vessel co-option and resistance to anti-angiogenic therapy.
Kuczynski EA; Reynolds AR
Angiogenesis; 2020 Feb; 23(1):55-74. PubMed ID: 31865479
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?
Coelho AL; Gomes MP; Catarino RJ; Rolfo C; Lopes AM; Medeiros RM; Araújo AM
Oncotarget; 2017 Jun; 8(24):39795-39804. PubMed ID: 26950275
[TBL] [Abstract][Full Text] [Related]
7. Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma.
Kuczynski EA; Yin M; Bar-Zion A; Lee CR; Butz H; Man S; Daley F; Vermeulen PB; Yousef GM; Foster FS; Reynolds AR; Kerbel RS
J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27059374
[TBL] [Abstract][Full Text] [Related]
8. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.
Frentzas S; Simoneau E; Bridgeman VL; Vermeulen PB; Foo S; Kostaras E; Nathan M; Wotherspoon A; Gao ZH; Shi Y; Van den Eynden G; Daley F; Peckitt C; Tan X; Salman A; Lazaris A; Gazinska P; Berg TJ; Eltahir Z; Ritsma L; Van Rheenen J; Khashper A; Brown G; Nystrom H; Sund M; Van Laere S; Loyer E; Dirix L; Cunningham D; Metrakos P; Reynolds AR
Nat Med; 2016 Nov; 22(11):1294-1302. PubMed ID: 27748747
[TBL] [Abstract][Full Text] [Related]
9. The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers.
Shao Y; Lu B
Cancer Metastasis Rev; 2022 Mar; 41(1):173-191. PubMed ID: 34664157
[TBL] [Abstract][Full Text] [Related]
10. Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
Donnem T; Hu J; Ferguson M; Adighibe O; Snell C; Harris AL; Gatter KC; Pezzella F
Cancer Med; 2013 Aug; 2(4):427-36. PubMed ID: 24156015
[TBL] [Abstract][Full Text] [Related]
11. Pathological features of vessel co-option versus sprouting angiogenesis.
Latacz E; Caspani E; Barnhill R; Lugassy C; Verhoef C; Grünhagen D; Van Laere S; Fernández Moro C; Gerling M; Dirix M; Dirix LY; Vermeulen PB
Angiogenesis; 2020 Feb; 23(1):43-54. PubMed ID: 31655928
[TBL] [Abstract][Full Text] [Related]
12. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution.
Fleischer JR; Schmitt AM; Haas G; Xu X; Zeisberg EM; Bohnenberger H; Küffer S; Teuwen LA; Karras PJ; Beißbarth T; Bleckmann A; Planque M; Fendt SM; Vermeulen P; Ghadimi M; Kalucka J; De Oliveira T; Conradi LC
Mol Cancer; 2023 Jan; 22(1):17. PubMed ID: 36691028
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment conditions that favor vessel co-option in colorectal cancer liver metastases: A theoretical model.
Rada M; Lazaris A; Kapelanski-Lamoureux A; Mayer TZ; Metrakos P
Semin Cancer Biol; 2021 Jun; 71():52-64. PubMed ID: 32920126
[TBL] [Abstract][Full Text] [Related]
14. Generation of vessel co-option lung metastases mouse models for single-cell isolation of metastases-derived cells and endothelial cells.
Cuypers A; Teuwen LA; Bridgeman VL; de Rooij LPMH; Eelen G; Dewerchin M; Cantelmo AR; Kalucka J; Bouché A; Vinckier S; Carton A; Manderveld A; Vermeulen PB; Reynolds AR; Carmeliet P
STAR Protoc; 2022 Dec; 3(4):101691. PubMed ID: 36173713
[TBL] [Abstract][Full Text] [Related]
15. Vessel co-option: a unique vascular-immune niche in liver cancer.
Yang D; Dang S; Wang Z; Xie M; Li X; Ding X
Front Oncol; 2024; 14():1386772. PubMed ID: 38737903
[TBL] [Abstract][Full Text] [Related]
16. Vessel co-option in glioblastoma: emerging insights and opportunities.
Seano G; Jain RK
Angiogenesis; 2020 Feb; 23(1):9-16. PubMed ID: 31679081
[TBL] [Abstract][Full Text] [Related]
17. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies.
Lazaris A; Amri A; Petrillo SK; Zoroquiain P; Ibrahim N; Salman A; Gao ZH; Vermeulen PB; Metrakos P
J Pathol Clin Res; 2018 Jul; 4(3):184-192. PubMed ID: 29654716
[TBL] [Abstract][Full Text] [Related]
18. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
19. Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers.
Olejarz W; Kubiak-Tomaszewska G; Chrzanowska A; Lorenc T
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823989
[TBL] [Abstract][Full Text] [Related]
20. Vessel co-option in cancer.
Kuczynski EA; Vermeulen PB; Pezzella F; Kerbel RS; Reynolds AR
Nat Rev Clin Oncol; 2019 Aug; 16(8):469-493. PubMed ID: 30816337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
